Trend.MED, a leading Austrian medical business publication, covered Innophore’s work on applying AI and structural bioinformatics to the fight against SARS-CoV-2. The article discusses how the company’s computational platform enables rapid analysis of viral protein structures, supporting both drug discovery and variant surveillance efforts.